Micro-costing analysis of suspected lower respiratory tract infection care in a French emergency department.

cost analysis emergency department health economics micro-costing respiratory infections

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2023
Historique:
received: 11 08 2023
accepted: 21 09 2023
medline: 23 10 2023
pubmed: 20 10 2023
entrez: 20 10 2023
Statut: epublish

Résumé

In the context of budgetary constraints faced by healthcare systems, the medical-economic evaluation of care strategies becomes essential. In particular, valuing consumed resources in the overcrowded emergency departments (EDs) has become a priority to adopt more efficient approaches in treating the growing number of patients. However, precisely measuring the cost of care is challenging. While bottom-up micro-costing is considered the gold standard, its practical application remains limited. The objective was to accurately estimate the ED care cost for patients consulting in a French ED for suspected lower respiratory tract infection. The authors conducted a cost analysis using a bottom-up micro-costing method. Patients were prospectively included between January 1, and March 31, 2023. The primary endpoint was the mean cost of ED care. Resources consumed were collected using direct observation method and cost data were obtained from information available at Strasbourg University Hospital. The mean cost of ED care was €411.68 (SD = 174.49). The cost elements that made the greatest contribution to the total cost were laboratory tests, labor, latency time, imaging and consumables. Considering this cost and the current epidemiological data on respiratory infections in France, the absence of valuation for outpatient care represents an annual loss of over 17 million euros for healthcare facilities. Micro-costing is a key element in valuing healthcare costs. The importance of accurately measuring costs, along with measuring the health outcomes of a defined care pathway, is to enhance the relevance of health economic evaluations and thus ensure efficient care.

Identifiants

pubmed: 37860807
doi: 10.3389/fpubh.2023.1276373
pmc: PMC10582559
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1276373

Informations de copyright

Copyright © 2023 Wilmé, Sauleau, Le Borgne, Bayle, Bilbault and Kepka.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Healthc Manag. 2020 Nov-Dec;65(6):419-428
pubmed: 33186257
Rev Epidemiol Sante Publique. 2018 Mar;66 Suppl 2:S73-S91
pubmed: 29530439
Eur J Health Econ. 2009 Feb;10(1):39-45
pubmed: 18340472
J Am Coll Radiol. 2019 Jan;16(1):30-38
pubmed: 30158081
Rev Epidemiol Sante Publique. 2018 Mar;66 Suppl 2:S65-S72
pubmed: 29525184
Ann Emerg Med. 2016 Jun;67(6):765-772
pubmed: 26365921
Harv Bus Rev. 2011 Sep;89(9):46-52, 54, 56-61 passim
pubmed: 21939127
J Am Coll Emerg Physicians Open. 2022 Jul 18;3(4):e12778
pubmed: 35865131
Mayo Clin Proc Innov Qual Outcomes. 2019 Feb 26;3(1):30-34
pubmed: 30899906
Ir J Med Sci. 2000 Oct-Dec;169(4):241-4
pubmed: 11381789
Rev Med Interne. 2020 Oct;41(10):693-699
pubmed: 32861534
Urology. 2021 Nov;157:107-113
pubmed: 34391774
Healthcare (Basel). 2022 Aug 25;10(9):
pubmed: 36141237
Eur J Health Econ. 2020 Jun;21(4):529-542
pubmed: 31960181
Pharmacoeconomics. 2017 Feb;35(2):129-139
pubmed: 27838912
Clin Microbiol Infect. 2022 Dec;28(12):1651.e1-1651.e8
pubmed: 35738321
Am J Manag Care. 2020 Sep;26(9):369-370
pubmed: 32930548
Med Care. 1999 Apr;37(4 Suppl Va):AS3-8
pubmed: 10217379
Health Econ. 2009 Apr;18(4):377-88
pubmed: 18615835
Health Econ. 1995 Jan-Feb;4(1):31-9
pubmed: 7780526
JMIR Res Protoc. 2021 Feb 22;10(2):e25619
pubmed: 33616548

Auteurs

Valérie Wilmé (V)

Emergency Department, Strasbourg University Hospital, Strasbourg, France.

Érik-André Sauleau (ÉA)

Public Health Department, Strasbourg University Hospital, Strasbourg, France.
ICube Laboratory, French National Center for Scientific Research (CNRS), UMR 7357, University of Strasbourg, Illkirch-Graffenstaden, France.

Pierrick Le Borgne (P)

Emergency Department, Strasbourg University Hospital, Strasbourg, France.
Regenerative NanoMedicine (RNM) and Federation of Translational Medicine (FMTS), French National Institute of Health and Medical Research (INSERM), UMR 1260, University of Strasbourg, Strasbourg, France.

Éric Bayle (É)

Emergency Department, Strasbourg University Hospital, Strasbourg, France.

Pascal Bilbault (P)

Emergency Department, Strasbourg University Hospital, Strasbourg, France.
Regenerative NanoMedicine (RNM) and Federation of Translational Medicine (FMTS), French National Institute of Health and Medical Research (INSERM), UMR 1260, University of Strasbourg, Strasbourg, France.

Sabrina Kepka (S)

Emergency Department, Strasbourg University Hospital, Strasbourg, France.
Public Health Department, Strasbourg University Hospital, Strasbourg, France.
ICube Laboratory, French National Center for Scientific Research (CNRS), UMR 7357, University of Strasbourg, Illkirch-Graffenstaden, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH